XML 120 R104.htm IDEA: XBRL DOCUMENT v3.6.0.2
Business Combinations and Divestitures - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Feb. 15, 2017
Jan. 26, 2017
Mar. 31, 2017
Oct. 02, 2016
Jan. 01, 2017
Jan. 03, 2016
Dec. 28, 2014
Dec. 30, 2012
Business Acquisition [Line Items]                
Acquisition payments         $ 4,509 $ 954 $ 2,129  
Liabilities assumed         77 220 38  
Contingent consideration           210    
Indefinite lived intangible assets         10,331 10,443    
Purchase price         4,509 954 2,129  
Gain on divestitures, pre-tax         600 2,600 2,400  
2016 Acquisitions [Member]                
Business Acquisition [Line Items]                
Purchase price over fair value of assets acquired         $ 4,077      
Vogue International LLC [Member]                
Business Acquisition [Line Items]                
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life         22 years      
Abbott Medical Optics [Member]                
Business Acquisition [Line Items]                
Business Combination, Pending Purchase Price       $ 4,325        
2015 acquisitions [Member]                
Business Acquisition [Line Items]                
Purchase price over fair value of assets acquired           $ 1,173    
XO1                
Business Acquisition [Line Items]                
Probability of success (as a percent)           36.00%    
Discount rate (as a percent)           11.75%    
2014 Acquisitions                
Business Acquisition [Line Items]                
Purchase price over fair value of assets acquired             $ 2,069  
Alios Biopharma                
Business Acquisition [Line Items]                
Probability of success (as a percent)             60.00%  
Discount rate (as a percent)             11.40%  
Covagen AG                
Business Acquisition [Line Items]                
Probability of success (as a percent)             26.00%  
Discount rate (as a percent)             12.50%  
Synthes, Inc                
Business Acquisition [Line Items]                
Purchase price               $ 20,200
OCD                
Business Acquisition [Line Items]                
Gain on divestitures, pre-tax             $ 1,900  
Proceeds from divestiture             4,000  
Purchased in-process research and development                
Business Acquisition [Line Items]                
Indefinite lived intangible assets         $ 3,443 $ 3,420    
Purchased in-process research and development | XO1 and Novira Therapeutics                
Business Acquisition [Line Items]                
Indefinite lived intangible assets           839    
Purchased in-process research and development | XO1                
Business Acquisition [Line Items]                
Indefinite lived intangible assets           360    
Purchased in-process research and development | Novira                
Business Acquisition [Line Items]                
Indefinite lived intangible assets           $ 396    
Probability of success (as a percent)           51.00%    
Discount rate (as a percent)           16.00%    
Purchased in-process research and development | Alios and Covagen [Member]                
Business Acquisition [Line Items]                
Indefinite lived intangible assets             1,913  
Purchased in-process research and development | Alios Biopharma                
Business Acquisition [Line Items]                
Indefinite lived intangible assets             1,688  
Purchased in-process research and development | Covagen AG                
Business Acquisition [Line Items]                
Indefinite lived intangible assets             $ 225  
Consumer | Vogue International LLC [Member]                
Business Acquisition [Line Items]                
Acquisition payments         3,300      
Finite-lived Intangible Assets Acquired         2,300      
Business Acquisition, Goodwill, Expected Tax Deductible Amount         $ 1,100      
Trademarks | Vogue International LLC [Member]                
Business Acquisition [Line Items]                
Finite-Lived Intangible Asset, Useful Life         22 years      
Trademarks | Maximum | Vogue International LLC [Member]                
Business Acquisition [Line Items]                
Finite-Lived Intangible Asset, Useful Life         22 years      
Trademarks | Minimum | Vogue International LLC [Member]                
Business Acquisition [Line Items]                
Finite-Lived Intangible Asset, Useful Life         10 years      
Subsequent Event [Member] | Actelion [Member]                
Business Acquisition [Line Items]                
Acquisition payments     $ 30,000          
Acquisition price (in dollars per share)   $ 280            
Subsequent Event [Member] | R&D NewCo [Member]                
Business Acquisition [Line Items]                
Business Acquisition, Percentage of Voting Interests Acquired   16.00%            
Convertible Note, Equity Interest, Percentage   16.00%            
Codman Neurosurgery [Member] | Subsequent Event [Member]                
Business Acquisition [Line Items]                
Proceeds from Divestiture of Businesses $ 1,000